Algorithm Accurately Predicts Heart Failure Survival
|
By HospiMedica International staff writers Posted on 30 May 2018 |

Image: The Trees of Predictors algorithm uses machine learning and 53 data points to more accurately predict life expectancy after heart failure (Photo courtesy of UCLA).
A team of researchers from UCLA (Los Angeles, USA) have developed a new algorithm that more accurately predicts which people will survive heart failure and for how long, as well as whether they will receive a heart transplant or not. The algorithm will allow doctors to carry out more personalized assessments of people awaiting heart transplants, thus enabling health care providers to efficiently use limited life-saving resources and reduce health care costs.
The algorithm, named Trees of Predictors, uses machine learning and takes into consideration 53 data points, including age, gender, body mass index, blood type and blood chemistry, to address the differences between people awaiting heart transplants and the compatibility between potential heart transplant recipients and donors. Using these data points, the algorithm predicts how long people with heart failure will live, depending upon whether they will receive a transplant or not. The algorithm can also analyze different possible risk scenarios for potential transplant candidates in order to assist doctors to more thoroughly assess people who can be candidates for heart transplants, and is flexible enough to incorporate more data as treatments evolve.
The UCLA researchers tested the algorithm using 30 years of data on people registered with the United Network for Organ Sharing, a non-profit organization that matches donors and transplant recipients in the US. The researchers found the algorithm provided significantly better predictions than the prediction models currently used by most doctors to project, which transplant recipients would live for at least three years after a transplant. The UCLA algorithm outperformed the models by 14% by correctly predicting that 2,442 more heart transplant recipients of the 17,441 who had received transplants and lived at least that long after the surgery. According to the researchers, the Trees of Predictors algorithm can also be used to gather insights from medical databases and various other types of complex databases.
“Our work suggests that more lives could be saved with the application of this new machine-learning–based algorithm,” said Mihaela van der Schaar, Chancellor’s Professor of Electrical and Computer Engineering at the UCLA Samueli School of Engineering, who led the study. “It would be especially useful for determining which patients need heart transplants most urgently and which patients are good candidates for bridge therapies such as implanted mechanical-assist devices.”
“Following this method, we are able to identify a significant number of patients who are good transplant candidates but were not identified as such by traditional approaches,” said Dr. Martin Cadeiras, a cardiologist at the David Geffen School of Medicine at UCLA. “This methodology better resembles the human thinking process by allowing multiple alternative solutions for the same problem but taking into consideration the variability of each individual.”
Related Links:
UCLA
The algorithm, named Trees of Predictors, uses machine learning and takes into consideration 53 data points, including age, gender, body mass index, blood type and blood chemistry, to address the differences between people awaiting heart transplants and the compatibility between potential heart transplant recipients and donors. Using these data points, the algorithm predicts how long people with heart failure will live, depending upon whether they will receive a transplant or not. The algorithm can also analyze different possible risk scenarios for potential transplant candidates in order to assist doctors to more thoroughly assess people who can be candidates for heart transplants, and is flexible enough to incorporate more data as treatments evolve.
The UCLA researchers tested the algorithm using 30 years of data on people registered with the United Network for Organ Sharing, a non-profit organization that matches donors and transplant recipients in the US. The researchers found the algorithm provided significantly better predictions than the prediction models currently used by most doctors to project, which transplant recipients would live for at least three years after a transplant. The UCLA algorithm outperformed the models by 14% by correctly predicting that 2,442 more heart transplant recipients of the 17,441 who had received transplants and lived at least that long after the surgery. According to the researchers, the Trees of Predictors algorithm can also be used to gather insights from medical databases and various other types of complex databases.
“Our work suggests that more lives could be saved with the application of this new machine-learning–based algorithm,” said Mihaela van der Schaar, Chancellor’s Professor of Electrical and Computer Engineering at the UCLA Samueli School of Engineering, who led the study. “It would be especially useful for determining which patients need heart transplants most urgently and which patients are good candidates for bridge therapies such as implanted mechanical-assist devices.”
“Following this method, we are able to identify a significant number of patients who are good transplant candidates but were not identified as such by traditional approaches,” said Dr. Martin Cadeiras, a cardiologist at the David Geffen School of Medicine at UCLA. “This methodology better resembles the human thinking process by allowing multiple alternative solutions for the same problem but taking into consideration the variability of each individual.”
Related Links:
UCLA
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







